TRIM28 and central nervous system cancer: Qi et al. had reported that down-regulating TRIM28 increased p21 expression and induced cell cycle of glioma cells to arrest at the G1 phase, thereby exerted a critical influence on glioma progression, all evidence indicating TRIM28 role as an oncogenic contributor in glioma carcinogenesis [61].